secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonoma Pharmaceuticals, Inc. (SNOA)
CIK:        0001367083
Form:       8-K
Filed at:   2024-04-09T23:59:59+00:00
Accession:  0001683168-24-002224
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonoma Pharmaceuticals files updated investor presentation highlighting HOCl product portfolio and global reach
--------------------------------------------------------------------------------

- Presentation covers stabilized hypochlorous acid products for wound, eye, oral, nasal, and dermatological care.
- Products sold in 55 countries directly or through distribution partners.
- No new financial guidance, specific revenue figures, or material developments disclosed in the presentation.
- Company continues to seek new distribution partners for global expansion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367083/000168316824002224/0001683168-24-002224-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367083/000168316824002224/sonoma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-002224

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer